Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08DQZ
|
|||
| Former ID |
DNC012000
|
|||
| Drug Name |
4-Methyl-oxazolidin-(2Z)-ylideneamine
|
|||
| Synonyms |
CHEMBL105823; 4-methyl-4,5-dihydro-1,3-oxazol-2-amine; 68210-17-3; 4-Methyl-oxazolidin-(2Z)-ylideneamine; 4-Methyloxazolidine-2-imine; SCHEMBL6593982; SCHEMBL11825446; MolPort-004-802-126; BDBM50138202; AKOS006363611; NE17732
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C4H8N2O
|
|||
| Canonical SMILES |
CC1COC(=N1)N
|
|||
| InChI |
1S/C4H8N2O/c1-3-2-7-4(5)6-3/h3H,2H2,1H3,(H2,5,6)
|
|||
| InChIKey |
PIXPFRMNXPKTFS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: a new class of orally bioavailable nitric oxide synthase inhibitor. Bioorg Med Chem Lett. 2004 Jan 19;14(2):313-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.